225 related articles for article (PubMed ID: 34693502)
1. Whole-body MRI: detecting bone metastases from prostate cancer.
Nakanishi K; Tanaka J; Nakaya Y; Maeda N; Sakamoto A; Nakayama A; Satomura H; Sakai M; Konishi K; Yamamoto Y; Nagahara A; Nishimura K; Takenaka S; Tomiyama N
Jpn J Radiol; 2022 Mar; 40(3):229-244. PubMed ID: 34693502
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus
Sun W; Li M; Gu Y; Sun Z; Qiu Z; Zhou Y
AJR Am J Roentgenol; 2020 Feb; 214(2):446-454. PubMed ID: 31799866
[No Abstract] [Full Text] [Related]
3. Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases.
Stecco A; Lombardi M; Leva L; Brambilla M; Negru E; Delli Passeri S; Carriero A
Radiol Med; 2013 Apr; 118(3):465-75. PubMed ID: 22872462
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility and clinical value of whole body diffusion weighted magnetic resonance imaging in detection of bone metastases].
Li S; Xue HD; Sun F; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):192-9. PubMed ID: 19507599
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
[TBL] [Abstract][Full Text] [Related]
8. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
Jacobs MA; Macura KJ; Zaheer A; Antonarakis ES; Stearns V; Wolff AC; Feiweier T; Kamel IR; Wahl RL; Pan L
Acad Radiol; 2018 Nov; 25(11):1405-1414. PubMed ID: 29627288
[TBL] [Abstract][Full Text] [Related]
10. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
[TBL] [Abstract][Full Text] [Related]
12. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.
Nakanishi K; Kobayashi M; Nakaguchi K; Kyakuno M; Hashimoto N; Onishi H; Maeda N; Nakata S; Kuwabara M; Murakami T; Nakamura H
Magn Reson Med Sci; 2007; 6(3):147-55. PubMed ID: 18037795
[TBL] [Abstract][Full Text] [Related]
13. Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?
Petralia G; Padhani A; Summers P; Alessi S; Raimondi S; Testori A; Bellomi M
Eur Radiol; 2013 Dec; 23(12):3466-76. PubMed ID: 23884300
[TBL] [Abstract][Full Text] [Related]
14. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
[TBL] [Abstract][Full Text] [Related]
15. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
Gutzeit A; Doert A; Froehlich JM; Eckhardt BP; Meili A; Scherr P; Schmid DT; Graf N; von Weymarn CA; Willemse EM; Binkert CA
Skeletal Radiol; 2010 Apr; 39(4):333-43. PubMed ID: 20205350
[TBL] [Abstract][Full Text] [Related]
16. Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease.
Larbi A; Dallaudière B; Pasoglou V; Padhani A; Michoux N; Vande Berg BC; Tombal B; Lecouvet FE
Prostate; 2016 Aug; 76(11):1024-33. PubMed ID: 27197649
[TBL] [Abstract][Full Text] [Related]
17. Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance of incidental findings.
Kumasaka S; Motegi S; Kumasaka Y; Nishikata T; Otomo M; Tsushima Y
Br J Radiol; 2022 Mar; 95(1131):20210459. PubMed ID: 34111963
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.
Perez-Lopez R; Mateo J; Mossop H; Blackledge MD; Collins DJ; Rata M; Morgan VA; Macdonald A; Sandhu S; Lorente D; Rescigno P; Zafeiriou Z; Bianchini D; Porta N; Hall E; Leach MO; de Bono JS; Koh DM; Tunariu N
Radiology; 2017 Apr; 283(1):168-177. PubMed ID: 27875103
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
De Vuysere S; Vandecaveye V; De Bruecker Y; Carton S; Vermeiren K; Tollens T; De Keyzer F; Dresen RC
BMC Med Imaging; 2021 Feb; 21(1):18. PubMed ID: 33546626
[TBL] [Abstract][Full Text] [Related]
20. Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study.
Hottat NA; Badr DA; Ben Ghanem M; Besse-Hammer T; Lecomte SM; Vansteelandt C; Lecomte SL; Khaled C; De Grove V; Salem Wehbe G; Cannie MM; Jani JC
Eur Radiol; 2024 Jan; 34(1):165-178. PubMed ID: 37555959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
